학술논문
SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity
Document Type
Original Paper
Author
Huot, Nicolas; Rascle, Philippe; Petitdemange, Caroline; Contreras, Vanessa; Stürzel, Christina M.; Baquero, Eduard; Harper, Justin L.; Passaes, Caroline; Legendre, Rachel; Varet, Hugo; Madec, Yoann; Sauermann, Ulrike; Stahl-Hennig, Christiane; Nattermann, Jacob; Saez-Cirion, Asier; Le Grand, Roger; Keith Reeves, R.; Paiardini, Mirko; Kirchhoff, Frank; Jacquelin, Beatrice; Müller-Trutwin, Michaela
Source
Nature Communications. 12(1)
Subject
Language
English
ISSN
2041-1723
Abstract
Natural killer (NK) cells play a critical understudied role during HIV infection in tissues. In a natural host of SIV, the African green monkey (AGM), NK cells mediate a strong control of SIVagm infection in secondary lymphoid tissues. We demonstrate that SIVagm infection induces the expansion of terminally differentiated NKG2alow NK cells in secondary lymphoid organs displaying an adaptive transcriptional profile and increased MHC-E-restricted cytotoxicity in response to SIV Env peptides while expressing little IFN-γ. Such NK cell differentiation was lacking in SIVmac-infected macaques. Adaptive NK cells displayed no increased NKG2C expression. This study reveals a previously unknown profile of NK cell adaptation to a viral infection, thus accelerating strategies toward NK-cell directed therapies and viral control in tissues.
NK cells control SIV infection in secondary lymphoid tissues in the natural host that typically doesn’t progress toward disease. Here the authors show that this control is associated with terminal NK cell differentiation and improved MHC-E-dependent activity lacking in pathogenic SIV infection.
NK cells control SIV infection in secondary lymphoid tissues in the natural host that typically doesn’t progress toward disease. Here the authors show that this control is associated with terminal NK cell differentiation and improved MHC-E-dependent activity lacking in pathogenic SIV infection.